X-hexatoxin-Hi1a, Hi Gomesin

General Information


DRACP ID  DRACP03865

Peptide Name   X-hexatoxin-Hi1a, Hi Gomesin

Sequence  XCRRLCYRNRCVTYCRGR

Sequence Length  18

UniProt ID  A0A1D0BZI2 

PubChem CID  Not available

Origin  Animalia

Type  Native peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C87H146N36O21S4

Absent amino acids  ADEFHIKMPQSW

Common amino acids  R

Mass  257398

Pl  10.17

Basic residues  6

Acidic residues  0

Hydrophobic residues  2

Net charge  6

Boman Index  -8399

Hydrophobicity  -90

Aliphatic Index  37.78

Half Life 
  /

Extinction Coefficient cystines  3230

Absorbance 280nm  190

Polar residues  9

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 30068931

Title  Gomesin inhibits melanoma growth by manipulating key signaling cascades that control cell death and proliferation

Doi Not available

Year  2018

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  13885

DRACP is developed by Dr.Zheng's team.